ASX Share rice
Sun 16 May 2021 - 12:47:am (Sydney)

CYC Share Price

CYCLOPHARM LIMITEDCYCHealth Care Equipment & Services

CYC Company Information

Name:

Cyclopharm Limited

Sector:

Healthcare

Industry:

Medical Devices

GIC Industry:

Health Care Equipment & Supplies

GIC Sub Industry:

Health Care Equipment

Address:

1 The Crescent Kingsgrove NSW Australia 2208

Phone:

61 2 9541 0411

Full Time Employees:

48

CEO, MD, Company Sec. & Director:

Mr. James S. McBrayer F.A.C.I.D., BSPharm, GDM, FAICD, AIM

Chief Operating Officer:

Mr. Mathew Farag

Fin. Mang.:

Mr. Graham N. Phillips

Global Head of Regulatory Compliance & Clinical Research:

Dr. Mark Doverty

Head of Sales:

Ms. Sally-Ann Cornelius

Head of Quality and Regulatory:

Ms. Niamh McAree

Head of Service:

Mr. Chris Quinn

Financial Controller:

Ms. Sui Ling Cheah

Gen. Mang. of Canada:

Mr. Lynn McLauchlin

Quality & Regulatory Mang.:

Mr. Gary T. Somerville

Company Overview:

Cyclopharm Limited engages in the research and development, manufacture, and sale of medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. The company operates through Technegas and Molecular Imaging segments. It offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. The company also provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. It serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.

CYC Share Price Information

Shares Issued:

93.37M

Market Capitalisation:

$249.31M

Dividend per Share:

$0.01

Ex Dividend Date:

2021-04-01

Dividend Yield:

0.37%

Revenue (TTM):

$17.68M

Revenue Per Share (TTM):

$0.23

Earnings per Share:

$-0.035

Profit Margin:

-0.3418

Operating Margin (TTM):

$-0.28

Return On Assets (TTM):

$-0.10

Return On Equity (TTM):

$-0.30

Quarterly Revenue Growth (YOY):

0.134

Gross Profit(TTM):

$13.72M

Diluted Earnings Per Share (TTM):

$-0.079

QuarterlyEarnings Growth(YOY):

-0.833

CYC CashFlow Statement

CashFlow Date:

2020-12-31

Investments:

$-874,191

Change To Liabilities:

$2.25M

Total Cashflow From Investing Activities:

$-874,191

Net Borrowings:

$-289,758

Net Income:

$-6,043,636

Total Cash From Operating Activities:

$-8,934,868

Depreciation:

$0.91M

Other Cashflow From Investing Activities:

$-343,210

Dividends Paid:

$-752,419

Change To Inventory:

$-2,240,574

Change To Account Receivables:

$-1,783,104

Capital Expenditures:

$193.80K

CYC Income Statement

Income Date:

2020-12-31

Income Before Tax:

$-5,844,110

Net Income:

$-6,043,640

Gross Profit:

$10.72M

Operating Income:

$-5,636,250

Other Operating Expenses:

$-87,059

Interest Expense:

$18.22K

Income Tax Expense:

$199.53K

Total Revenue:

$14.68M

Cost Of Revenue:

$3.96M

CYC Balance Sheet

Balance Sheet Date:

2020-12-31

Intangible Assets:

$5.29M

Total Liabilities:

$11.16M

Total Stockholder Equity:

$17.12M

Other Current Liabilities:

$1.22M

Total Assets:

$28.28M

Common Stock:

$36.97M

Other Current Assets:

$297.37K

Retained Earnings:

$-15,657,242

Other Liabilities:

$0.92M

Good Will:

$865.27K

Other Assets:

$1.98M

Cash:

$1.87M

Total Current Liabilities:

$5.68M

Property - Plant & Equipment:

$5.81M

Net Tangible Assets:

$12.61M

Total Current Assets:

$15.98M

Net Receivables:

$9.07M

Short-Term Investments:

$12.30M

Inventory:

$4.74M

Accounts Payable:

$3.30M

Short-Term Investments:

$12.30

Non Current Liabilities Total:

$5.47M

CYC Share Price History

CYC News

05 May, 2021
YARDLEY, PA / ACCESSWIRE / May 5, 2021 / Jubilant Radiopharma, a business division of Jubilant Pharma Limited, and Cyclomedica Europe Ltd, a wholly owned subsidiary of Cyclopharm Limited (ASX:CYC), will announce their partnership at the International Conference on Nuclear Cardiology and Cardiac CT (ICNC), taking place on May 9-11, 2021.Under the terms of the agreement, Cyclomedica was appointed the exclusive distributor of Jubilant Radiopharma's state-of-art RUBY-FILL® (Rubidium Rb 82 Generator) for the European Economic Area (EEA).
27 Apr, 2021
Cyclopharm Limited ( ASX:CYC ) has exhibited strong share price growth in the past few years. However, its earnings...
01 Mar, 2021
Shareholders in Cyclopharm Limited ( ASX:CYC ) may be thrilled to learn that the covering analyst has just delivered a...
23 Feb, 2021
Every investor in Cyclopharm Limited ( ASX:CYC ) should be aware of the most powerful shareholder groups. Generally...
16 Dec, 2020
We can readily understand why investors are attracted to unprofitable companies. Indeed, Cyclopharm ( ASX:CYC ) stock...
01 Nov, 2020
Cyclopharm Limited (ASX:CYC) shareholders have seen the share price descend 13% over the month. But that doesn't...
16 Sep, 2020
The big shareholder groups in Cyclopharm Limited (ASX:CYC) have power over the company. Institutions often own shares...
24 Jul, 2020
Cyclopharm Limited's (ASX:CYC): Cyclopharm Limited engages in the research and development, manufacture, and sale of...
24 May, 2020
When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, you can make far...

CYC Dividend Payments

EX-Date Dividend Amount
2015-10-02$0.0050
2016-04-11$0.0050
2016-09-02$0.0050
2017-03-31$0.0050
2017-09-01$0.0050
2018-04-06$0.0050
2018-09-07$0.0050
2019-04-05$0.0050
2019-09-06$0.0050
2020-03-30$0.0050
2020-09-04$0.0050
2021-04-01$0.0050

CYC Dividends (last 7 Years)